Choi, Jin KyeongDambuza, Ivy MHe, ChangYu, Cheng-RongUche, Anita NMattapallil, Mary JCaspi, Rachel REgwuagu, Charles E2018-11-202018-11-202017-10-05Choi, J K, Dambuza, I M, He, C, Yu, C-R, Uche, A N, Mattapallil, M J, Caspi, R R & Egwuagu, C E 2017, 'IL-12p35 Inhibits Neuroinflammation and Ameliorates Autoimmune Encephalomyelitis', Frontiers in Immunology, vol. 8, 1258. https://doi.org/10.3389/fimmu.2017.012581664-3224PubMedCentral: PMC5633738http://hdl.handle.net/2164/11479The authors thank Rafael Villasmil (NEI FLOW Cytometry Core facility) and Dr. Venkat Mohanram (Laboratory of Immunology, NEI, NIH) for assistance with FACS analysis. NIH/NEI Intramural grant ZIA EY000262-21 (CE) and NIH/NEI Intramural grant ZIA EY000184-34 (RC) provided funding for this Research. The Supplementary Material for this article can be found online at https://www.frontiersin.org/article/10.3389/fimmu.2017.01258/full#supplementary-material.3396581engSDG 3 - Good Health and Well-beingbiologicalmultiple sclerosisexperimental autoimmune encephalomyelitisIL-12p35Breg cellsTreg cellsSTATscytokine signalingQR180 ImmunologyQR180IL-12p35 Inhibits Neuroinflammation and Ameliorates Autoimmune EncephalomyelitisJournal article10.3389/fimmu.2017.012588